Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Alliances symbols : ILMN save search
Illumina and GenoScreen Partner to Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis
Published: 2022-10-18 (Crawled : 11:00) - biospace.com/
ILMN | $124.41 3.46% 3.34% 1.3M
|
Health Technology
|
| O: 3.32%
H: 1.55%
C: -2.48%
genomic
GRAIL Announces Strategic Collaboration With AstraZeneca to Develop Companion Diagnostic Tests to Enable the Treatment of Early-Stage Cancer
Published: 2022-06-02 (Crawled : 17:00) - biospace.com/
ILMN | $124.41 3.46% 3.34% 1.3M
|
Health Technology
|
| O: -0.03%
H: 5.85%
C: 5.7%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
treatment collaboration diagnostic cancer test
GRAIL Announces Collaboration With U.S. Department of Veterans Affairs and the Veterans Health Foundation to Evaluate Galleri® Multi-Cancer Early Detection Test
Published: 2022-05-31 (Crawled : 17:00) - biospace.com/
ILMN | $124.41 3.46% 3.34% 1.3M
|
Health Technology
|
| O: -1.52%
H: 0.13%
C: -5.77%
galleri test collaboration health
SomaLogic and Illumina Combine Strengths to Propel Innovation in Proteomics
Published: 2022-01-06 (Crawled : 20:00) - biospace.com/
ILMN | $124.41 3.46% 3.34% 1.3M
|
Health Technology
|
| O: -0.14%
H: 4.37%
C: 3.15%
Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publicly Listed Company Pioneering Gene Circuit-Engineered Cell and Gene Therapies
Published: 2021-12-20 (Crawled : 13:00) - biospace.com/
DYNS 4 | $7.51 -6.13%
|
|
| O: -1.1%
H: 0.91%
C: -0.5%
SEER | $1.81 8.38% 7.73% 1.5M
|
Professional, Scientific, and T...
|
| O: -0.44%
H: 3.39%
C: 1.88%
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: -3.85%
H: 0.29%
C: -0.25%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: 16.86%
H: 0.0%
C: -13.98%
ILMN | $124.41 3.46% 3.34% 1.3M
|
Health Technology
|
| O: 1.49%
H: 0.18%
C: -2.23%
cel gene therapies gene therapy
Illumina Partners with Merck to Develop and Commercialize Companion Diagnostic and Research Tests for Use in Identifying Specific Cancer Mutations
Published: 2021-09-07 (Crawled : 14:00) - biospace.com/
MYGN | $18.595 0.57% 0.56% 510K
|
Health Technology
|
| O: 0.56%
H: 0.58%
C: -2.43%
ILMN | $124.41 3.46% 3.34% 1.3M
|
Health Technology
|
| O: -0.27%
H: 0.03%
C: -0.87%
test cancer research commercialization diagnostic
Microba Life Sciences and Illumina partner to accelerate microbiome research
Published: 2021-05-25 (Crawled : 17:00) - biospace.com/
ILMN | $124.41 3.46% 3.34% 1.3M
|
Health Technology
|
| O: 0.37%
H: 0.88%
C: -1.09%
life science research
Geneseeq Inks Deal with Illumina to Develop and Commercialize Comprehensive Cancer In-vitro Diagnostic NGS Kit in China
Published: 2021-03-16 (Crawled : 20:00) - biospace.com/
ILMN | $124.41 3.46% 3.34% 1.3M
|
Health Technology
|
| O: 0.18%
H: 1.06%
C: -0.36%
china cancer commercialization diagnostic in vitro
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.